Our Legal Basis
The World Diabetes Foundation is an independent and non-profit foundation governed by the Danish Foundation Act.
The Foundation is supervised by the Civil Affairs Agency, Denmark's authority for non-commercial foundations.
The intention to establish the World Diabetes Foundation was announced by Novo Nordisk A/S on World Diabetes Day 2001. WDF is supported by four endowments from the shareholders of Novo Nordisk A/S:
1. In March 2002, they approved a first deed of gift of maximum DKK 650 million for the period 2001 - 2010 (realised: DKK 531 million)
2. In March 2008, they approved a second endowment of a maximum of DKK 575 million over another 10-year period (realised: DKK 480 million).
3. Extraordinary donation of DKK 25 million for the years 2011/12 in support of the UN High Level Meeting on the Prevention and Control of Non-communicable Diseases.
4. In March 2014, they approved a fourth endowment of a maximum DKK 654 million over a third 10-year period (on-going)
This brings the endowments up to DKK 1.69 billion in the period of 2001-2024 (approx. USD 277 million). (The actual sum may vary, depending on the operating results of Novo Nordisk A/S in the coming years.)
Photo: The World Diabetes Foundation's Board of Directors in December, 2017.
(Updated Aug 2018)